Current Medical Hot Topics (US)

Coverage and cost, the post-Dobbs landscape, the overdose crisis, firearm injury, maternal mortality, vaccine policy and AI — with the 2026 numbers and both sides of every argument. All on this page.

What actually changed in 2026 — ACA subsidies, Medicaid, the immunization schedule

The overdose crisis, and why deaths are falling faster than most applicants realise

Firearm injury framed as public health, including the fact most applicants miss

Maternal mortality and why the disparity survives controlling for income

AI in medicine beyond “bias and privacy” — accountability and automation bias

A structure for answering a policy question without becoming partisan

No spam, unsubscribe anytime

Current Medical Hot Topics (US) guide cover

The 2027 briefing: what changed this cycle

Interviewers rarely ask a current-affairs question to check whether you read the news. They ask because holistic review requires them to assess attributes a transcript cannot show: whether you understand the system you are asking to enter, whether you can hold a position without becoming partisan, and whether you have connected what you saw on a scribe shift to something larger than one patient.

Everything below changed between the 2025 and 2027 application cycles. If your preparation rests on material written before 2026, it is out of date in ways an interviewer will notice.

Development	Where it stands for the 2027 cycle
Enhanced ACA subsidies	Expired 1 January 2026. Marketplace insurers requested median premium increases of about 18% for 2026, the steepest since 2018, with millions projected to lose marketplace coverage.
Medicaid	Cut substantially by the July 2025 reconciliation law, with CBO projecting millions losing coverage over a decade — driven largely by work requirements and eligibility verification.
Childhood immunization schedule	A reconstituted ACIP recommended reducing routinely covered diseases from 17 to 11; a federal court stayed the revised 2026 schedule and the new appointments in March 2026. Genuinely unresolved.
Drug overdose deaths	Falling sharply. CDC provisional data projected 69,147 deaths for the 12 months to January 2026, down 13.2%, from a 2022 peak of 107,941.
Firearm deaths	Around 44,000 in 2024, a third consecutive annual decline, still among the highest totals on record.
Maternal mortality	17.9 per 100,000 live births in 2024, statistically unchanged from 18.6 in 2023. The rate for Black non-Hispanic women was 44.8, against 14.2 for White non-Hispanic women.
Abortion	Roughly 13 states enforce near-total bans, several more limits at around six weeks. The EMTALA preemption question remains legally unresolved.

Coverage, cost and access

American health care is financed through a patchwork rather than a system: employer-sponsored insurance for most working-age adults, Medicare for people 65 and over, Medicaid for people with low incomes with eligibility varying enormously by state, the ACA marketplaces for individual purchasers, the VA and Indian Health Service as direct-delivery systems, and no coverage at all for the remainder.

The United States spends far more per capita than any other wealthy country without correspondingly better outcomes — life expectancy is lower and maternal and infant mortality higher. Being able to say that the gap is driven largely by prices rather than utilisation is a strong opening to any cost question.

What the 2026 changes actually do

The enhanced premium tax credits enacted in 2021 and extended by the Inflation Reduction Act expired on 1 January 2026, and the combination of their loss and double-digit premium increases produced very large cost rises. Medicaid was reduced by the July 2025 reconciliation legislation, with CBO projecting millions losing coverage over the following decade.

The ethically interesting mechanism: Work requirements and more frequent eligibility redetermination remove people through administrative burden as much as through genuine ineligibility. A person fully eligible who loses coverage because a redetermination letter went to an old address has not been judged undeserving — they have been removed by paperwork. Naming administrative burden as a deliberate policy instrument is more sophisticated than “cuts are bad”.

Underinsurance and medical debt

The more contemporary problem is not the uninsured but the underinsured: people with coverage who cannot afford to use it because of deductibles, narrow networks and cost-sharing on chronic medications. Medical debt is a leading contributor to personal bankruptcy, and nonprofit hospitals with charity care obligations have historically pursued collection aggressively.

The honest framing: Rationing by price. The United States rations too — it simply does so through cost-sharing and coverage design rather than through waiting lists.

Drug pricing and the IRA

Americans pay considerably more for the same medicines than patients in peer countries, driven by the historical absence of Medicare price negotiation, pharmacy benefit manager incentives that favour high list prices, and patent strategies that delay generic entry. The Inflation Reduction Act granted Medicare negotiation authority for selected high-spend drugs, capped insulin cost-sharing at $35 a month for beneficiaries, and capped Part D out-of-pocket spending.

Run it both ways: Negotiation reduces cost and improves access now; industry argues it reduces the return that funds future development. The size of that innovation effect is genuinely contested, which is exactly why it makes a good interview question.

The overdose crisis — and why it is improving

This is one of the few genuinely good-news stories in American public health, and a candidate who knows the direction of travel stands out sharply from one who describes an unrelieved catastrophe. Overdose deaths peaked at 107,941 in 2022. CDC provisional data released in June 2026 projected 69,147 deaths for the twelve months ending January 2026 — a 13.2% decline and a continuation of a multi-year fall.

The reasons are contested and worth knowing, because the honest answer is that they are not entirely to our credit. Researchers have identified a change in the illicit fentanyl supply, including reduced potency, and reduced use in key populations — partly because so many of the most vulnerable have already died. Public health measures contributed: over-the-counter naloxone, expanded buprenorphine access after removal of the X-waiver, syringe services and fentanyl test strips.

The disparity is the part to remember: non-Hispanic Black Americans continue to die at roughly 1.4 times the national rate, so the aggregate improvement conceals a widening gap.
The crisis began in prescribing — aggressive marketing, pain as “the fifth vital sign”, and a thin evidence base for long-term opioid therapy in chronic non-cancer pain — then moved to heroin, then to illicit fentanyl now increasingly adulterated with xylazine, which does not respond to naloxone.
The correction caused its own harm: abrupt tapering and rigid prescribing limits harmed patients with legitimate chronic pain and pushed some toward a lethal illicit supply. A strong answer holds both harms at once.

Firearm injury as a public health problem

Around 44,000 people died of firearm injuries in the United States in 2024, the third consecutive annual decline but still among the highest totals on record.

More than half of firearm deaths are suicides, not homicides. This is the single most important fact in the topic and the one most applicants do not know.
Firearm injury is a leading cause of death for American children and adolescents, having overtaken motor vehicle crashes.
The burden is concentrated: homicide overwhelmingly affects young Black men, while firearm suicide rates are highest among older white men and in rural areas. It is really two epidemics with different demographics and different solutions.
The Dickey Amendment (1996) effectively chilled federal firearm injury research for about two decades; dedicated funding resumed in 2020, which is why the evidence base here is thinner than for almost any comparable cause of death.

Maternal mortality and health disparities

The United States has the highest maternal mortality rate in the developed world. The 2024 rate was 17.9 deaths per 100,000 live births, statistically unchanged from 18.6 in 2023. The rate for Black non-Hispanic women was 44.8 per 100,000, against 14.2 for White non-Hispanic, 12.1 for Hispanic and 18.1 for Asian non-Hispanic women.

Two further facts make the topic tractable. CDC maternal mortality review committees have consistently found that a large majority of pregnancy-related deaths are preventable, and a substantial proportion occur in the postpartum year rather than at delivery — which is why extending Medicaid postpartum coverage from 60 days to 12 months, now adopted by most states, is the clearest policy response.

Why the disparity persists

The evidence does not support a genetic explanation, and it does not support a purely socioeconomic one either: the disparity persists after controlling for income and education, and college-educated Black women have worse outcomes than white women without a high school diploma. The mechanisms identified are differential hospital quality, documented under-recognition and under-treatment of pain and symptoms reported by Black patients, the cumulative physiological cost of chronic stress and discrimination, and unequal access to prenatal and postpartum care.

Race-based clinical algorithms

The most concrete disparities example available. For decades the eGFR equation applied a correction factor for Black patients that raised estimated kidney function, delaying specialist referral and transplant listing; the race coefficient was removed following a 2021 NKF–ASN task force, and kidney waiting times were retrospectively adjusted. Similar corrections in spirometry and VBAC calculators have been revised or removed.

The general lesson: Treating race as a biological rather than a social variable embeds historical inequity into apparently objective tools. Being able to explain that is genuinely impressive.

Vaccines, trust and public health institutions

This is the most volatile topic in the guide and the one where currency matters most. Following the 2025 change of administration, the Secretary of Health and Human Services removed all seventeen sitting members of the Advisory Committee on Immunization Practices in June 2025 and appointed a reconstituted committee. In early 2026 federal officials announced a revised childhood immunization schedule reducing routinely covered diseases from 17 to 11, while retaining routine measles, polio and pertussis vaccination. In March 2026 a federal district court stayed the revised schedule and the new appointments.

The position is therefore genuinely unresolved as you apply, and it has coincided with significant measles outbreaks — a disease declared eliminated in the United States in 2000.

Speak to the evidence, not the personalities. The safety and effectiveness of the routine childhood vaccines are supported by a very large body of evidence, and you can say that plainly.
Take vaccine hesitancy seriously as a clinical problem. Most hesitant parents are anxious people who have encountered frightening claims, and the evidence on correcting misinformation shows that presuming bad faith entrenches it. Presumptive framing, motivational interviewing and the clinician’s own recommendation remain the most effective tools.
Distinguish the individual from the population. Vaccination is one of the clearest cases where autonomy and public health collide, because the benefit is partly conferred on people who cannot be vaccinated. School mandates with medical exemptions are the standard American resolution, and non-medical exemption policy is set state by state.

AI, burnout and the residency bottleneck

Every applicant expects an AI question, so the bar is specificity. And the workforce question is the best available answer to “what worries you about this career?”

AI: the four fault lines

Accountability — the physician remains responsible for the decision; AI is decision support and the malpractice framework has not meaningfully changed. Automation bias — the realistic risk is a tired clinician deferring to a confident output. Bias — a widely cited study found a commercial algorithm under-referred Black patients because it used historical cost as a proxy for need, and less had historically been spent on Black patients at equal illness severity; the algorithm did not use race at all. Validation — models are frequently deployed without independent prospective validation in the population where they will be used.

The sentence to have ready: AI in medicine is currently a decision-support tool and the accountable decision-maker is still the clinician. The risk I would worry about most is not the technology being wrong — it is automation bias.

Moral injury, not just burnout

Moral injury is the more precise term for much of what is described as burnout: the distress of knowing what good care requires and being structurally prevented from delivering it — by prior authorisation, documentation demands, fifteen-minute visits, a patient who cannot afford the drug you chose. The distinction matters because burnout implies the clinician needs resilience training while moral injury implies the system needs to change.

Worth knowing: The death of Dr Lorna Breen led to federal legislation supporting clinician mental health and a campaign to remove intrusive mental health questions from licensure and credentialing applications — fear of losing one’s licence has been a documented barrier to physicians seeking help.

The residency bottleneck

The binding constraint on the physician workforce is residency positions, not medical school places. Graduate medical education is funded largely through Medicare and was capped by the Balanced Budget Act of 1997, with only incremental increases since. Expanding medical schools without expanding residency does not produce more practising physicians — it produces more graduates competing for the same posts, carrying very large debt.

Why this is the answer to give: Asked what concerns you about medicine, the bottleneck, debt, moral injury and corporatisation are all far better answers than “long hours”, because they show you have looked at the profession as it actually is.

Answering a hot topics question

A hot topics question is rarely a knowledge test, and the follow-up is the real question. Prepare the second question, not the first.

Define the issue in one clear sentence.
Give a specific fact, with a number or a date.
Present the strongest argument on each side — genuinely, not a strawman you then knock down.
Take a position, with a caveat and a statement of what would change your mind.
Connect it to a clinical consequence or something you have personally observed.

The traps

Partisanship, in either direction. Fabricated precision — “around 44,000 firearm deaths a year” is fine, a fake decimal is not. Stale facts, since several topics here moved in 2026 and are under active litigation. Breadth without depth. And unrelieved pessimism: overdose deaths are falling, firearm deaths are falling, and a candidate who can describe genuine improvement and genuine inadequacy at the same time sounds like someone who reads data rather than headlines.

The bridge that wins

Stop treating current affairs as separate knowledge and start treating it as the analytical layer on experiences you already have. A patient who came to the ED because they had no primary care physician; a patient who rationed insulin; a scribe shift spent watching a physician fight a prior authorisation; a free clinic patient who could not take time off to attend follow-up. An interviewer has heard the uninsured rate before. They have not heard your account of the woman who came in for the third time that year.

Frequently asked questions

Coverage and cost after the enhanced ACA subsidies expired on 1 January 2026 and Medicaid was cut in July 2025; the post-Dobbs state patchwork and the unresolved EMTALA question; the overdose crisis, where deaths fell 13.2% to a projected 69,147; firearm injury; maternal mortality and disparities; vaccine policy and the stayed 2026 immunization schedule; AI in clinical practice; and the residency bottleneck.

Down, substantially. Deaths peaked at 107,941 in 2022 and CDC provisional data projected 69,147 for the twelve months to January 2026, a 13.2% decline. The drivers include a change in the illicit fentanyl supply, reduced use in key populations, and public health measures such as over-the-counter naloxone and expanded buprenorphine access. Non-Hispanic Black Americans still die at roughly 1.4 times the national rate, so the aggregate improvement conceals a widening disparity.

The 2024 rate was 17.9 deaths per 100,000 live births, the highest in the developed world, and the rate for Black non-Hispanic women was 44.8 against 14.2 for White non-Hispanic women. The disparity persists after controlling for income and education, so socioeconomic status alone cannot explain it. The mechanisms identified are differential hospital quality, under-recognition of symptoms reported by Black patients, the physiological cost of chronic stress and discrimination, and unequal access to prenatal and postpartum care.

Stay on the clinical and evidentiary ground you actually occupy: what happens to patients, what the data show, and who bears the trade-off. Define the issue, give one specific fact, present the strongest version of both sides, take a position with a caveat and a falsifier, then connect it to something you have personally seen. Interviewers are not asking you to declare a party — they are testing whether you can reason about a contested question without joining a team.

Go beyond “bias and data privacy”, which is now the baseline. The most useful single sentence is that AI is currently a decision-support tool and the accountable decision-maker remains the clinician. Then name automation bias as the realistic risk, and use the commercial care-management algorithm that under-referred Black patients because it used historical cost as a proxy for need — it did not use race at all, and bias entered through the choice of target variable.

Turn these into answers you can defend

Knowing the facts is the easy half. Book a mock interview with a tutor who will probe your second answer, or take the full PDF version of this guide with you.

Get instant access to your free guide

Drop your details in and your Current Medical Hot Topics (US) unlocks straight away — no waiting on an email.